TRVI - Trevi Therapeutics, Inc.
IEX Last Trade
4.38
0.050 1.142%
Share volume: 12,507
Last Updated: Fri 27 Dec 2024 08:30:25 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$4.33
0.05
1.15%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |